Abstract

Fentanyl is a potent synthetic opioid used as a general anesthetic and analgetic. Fatal outcome from intravenous misuse of transdermal fentanyl is rare, and there are few such reports in literature. Here we report two cases of fatal intravenous injection of the content from fentanyl patches. Both were male drug addicts, found dead within a one week interval in the same apartment. Post-mortem femoral blood was screened for amphetamines, cannabinoids, cocaine, and opioids with immunological methods (EMIT II) and further with headspace gas chromatography for alcohol and with liquid chromatography mass spectrometry (LC-MS) for different drugs, including fentanyl. Confirmatory analysis of fentanyl and morphine was performed by gas chromatography-mass spectrometry (GC-MS). In the first case, the toxicological analysis revealed fentanyl (2.7 ng/mL), morphine (31.4 ng/mL), and ethanol (1.1 g/L) in postmortem blood and amphetamine, cannabinoids, morphine, and ethanol (1.4 g/L) in postmortem urine. In the second case, the analysis revealed fentanyl (13.8 ng/mL), 7-aminoclonazepam (57.1 ng/mL), and sertralin (91.9 ng/mL) in postmortem blood and a small amount of ethanol (0.1 g/L) in postmortem urine. Police investigation revealed that both the deceased had bought the patches from the same source. The present cases demonstrate the possibility of intravenous misuse of transdermal patches and the risk of fatal outcome.

References

1.
Gutstein
HB
,
Akil
H
.
Opioid analgetics
. In:
Hardman
JG
,
Limbird
LE
,
Goodman Gilman
A
, Eds. Goodman and Gilman:
The pharmacologi cal basis of therapeutics
. 10th ed.
New York
:
McGraw-Hill
,
2001
;
569
619
.
2.
Gupta
SK
,
Southam
M
,
Gale
R
,
Hwang
SS
.
System functionality and physiocochemical model of fentanyl transdermal system
.
J Pain Symptom Manage
 0885-3924
1992
;
7
:
17
26
.
3.
Reeves
MD
,
Ginifer
CJ
.
Fatal intravenous misuse of transdermal fentanyl
.
Med J Aust
 0025-729X
2002
;
177
(
10
):
552
3
.
4.
Marquardt
KA
,
Tharratt
RS
.
Inhalation abuse of fentanyl patch
.
J Toxicol Clin Toxicol
 0731-3810
1994
;
32
(
1
):
75
8
.
5.
Kramer
C
,
Tawney
M
.
A fatal overdose of transdermally administered fentanyl
.
J Am Osteopath Assoc
 0003-0287
1998
;
98
(
7
):
385
6
.
6.
Flannagan
LM
,
Butts
JD
,
Anderson
WH
.
Fentanyl patches left on dead bodies-potential source of drug for abusers
.
J Forensic Sci
 0022-1198
1996
;
41
(
2
):
320
1
.
7.
DeSio
JM
,
Bacon
DR
,
Peer
G
,
Lema
MJ
.
Intravenous abuse of transdermal fentanyl therapy in a chronic pain patient
.
Anesthesiology
 0003-3022
1993
;
79
(
5
):
1139
41
.
8.
Kuhlman
JJ
,
McCaully
R
,
Valouch
TJ
,
Behonick
GS
.
Fentanyl use, misuse, and abuse: A summary of 23 postmortem cases
.
J Anal Toxicol
 0146-4760
2003
;
27
:
499
504
.
9.
Fung
DL
,
Eisele
JH
.
Fentanyl pharmacokinetics in awake volunteers
.
J Clin Pharmacol
 0091-2700
1980
;
20
(
1 1–12
):
652
8
.
10.
Henderson
GL
.
Fentanyl-related deaths: demographics, circumstances, and toxicology of 112 cases
.
J Forensic Sci
 0022-1198
1991
;
36
(
2
):
422
33
.
11.
Poklis
A
.
Fentanyl: a review for clinical and analytical toxicologists
.
J Toxicol Clin Toxicol
 0731-3810
1995
;
33
(
5
):
439
17
.
12.
Gourlay
GK
,
Kowalski
SR
,
Plummer
JL
,
Cousins
MJ
,
Armstrong
PJ
.
Fentanyl blood concentration—analgesic response relationship in the treatment of postoperative pain
.
Anesth Analg
 0003-2999
1988
;
67
(
4
):
329
37
.
13.
Marquardt
KA
,
Tharratt
RS
,
Musallam
NA
.
Fentanyl remaining in a transdermal system following three days of continous use
.
Ann Pharmacother
 1060-0280 1995 Oct.;29(
10
):
969
71
.
This content is only available via PDF.
You do not currently have access to this content.